Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accentis S.A. | D1Z | Nov 21, 2024 | 0.02 | 0.00 |
Accentro Real Estate AG | A4Y | Nov 21, 2024 | 0.22 | -19.57 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Nov 21, 2024 | 345.85 | +3.39 |
Accesso Technology Group Plc | LQG | Nov 21, 2024 | 6.25 | -3.85 |
Acciona SA | AJ3 | Nov 21, 2024 | 114.90 | +0.44 |
Acco Brands Corporation | A3B | Nov 21, 2024 | 5.35 | 0.00 |
Accolade, Inc. | 4NE1 | Nov 21, 2024 | 3.34 | +2.45 |
Acconeer | 2LU | Nov 21, 2024 | 0.42 | +0.24 |
Accor | ACR1 | Nov 21, 2024 | 8.40 | -1.75 |
Accor SA | ACR | Nov 21, 2024 | 42.81 | -0.90 |
Accsys Technologies | 1D8 | Nov 21, 2024 | 0.50 | -4.55 |
Accuray Incorporated | XEJ | Nov 21, 2024 | 1.71 | 0.00 |
Ace Hardware Indonesia TBK | 4AH1 | Nov 21, 2024 | 0.04 | -1.22 |
ACE LIBERTY+STONE LS -,25 | 8MW | Nov 21, 2024 | 0.54 | 0.00 |
ACEA SpA | DCA | Nov 21, 2024 | 17.34 | +1.88 |
AcelRx Pharmaceuticals | R5XA | Nov 21, 2024 | 0.66 | +5.48 |
Acer Incorporated | AC5G | Nov 21, 2024 | 4.60 | 0.00 |
ACERINOX ADR 1/2/EO-,25 | ACE | Nov 21, 2024 | 4.28 | +0.47 |
Acerinox SA | ACE1 | Nov 21, 2024 | 9.16 | +2.46 |
Achieve Life Sciences, Inc. - | SP4P | Nov 21, 2024 | 4.00 | -0.12 |
Achilles Therapeutics plc - American Depositary Shares | 698 | Nov 21, 2024 | 0.96 | +1.05 |
ACI Worldwide, Inc. | TSA | Nov 21, 2024 | 52.50 | +1.94 |
ACINQUE S.P.A. EO 1 | YA2 | Nov 21, 2024 | 1.94 | +0.78 |
Ackermans & van Haaren NV | B3K | Nov 21, 2024 | 186.00 | +0.22 |
Aclara Resources Inc | JD1 | Nov 21, 2024 | 0.26 | +7.44 |
Aclaris Therapeutics, Inc. | 8AT | Nov 21, 2024 | 3.77 | -16.53 |
ACM Research, Inc. - Class A | 813 | Nov 21, 2024 | 18.23 | +6.27 |
Acma Ltd | AAX1 | Nov 21, 2024 | 0.01 | -42.86 |
Acme United Corporation. | UT1 | Nov 21, 2024 | 38.80 | -0.51 |
Acom Co Ltd | AK5 | Nov 21, 2024 | 2.30 | -2.54 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.